Published on 5 May 2021 on Zacks via Yahoo Finance
Jazz Pharma (JAZZ) Q1 Earnings Beat, Sales Miss, Stock Down
Jazz Pharmaceuticals JAZZ delivered adjusted earnings of $3.92 per share for the first quarter of...
The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More
Benzinga spoke with Irwin Simon, CEO of the new combined company. Jazz Pharmaceuticals (NASDAQ:...
New Strong Sell Stocks for May 6th
Holding Inc. CDAY is a human capital management software company. The Zacks Consensus Estimate fo...
Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio
The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition ...
Jazz Pharma (JAZZ) Q1 Earnings Beat, Sales Miss, Stock Down
Jazz Pharmaceuticals JAZZ delivered adjusted earnings of $3.92 per share for the first quarter of...
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter,...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Pea...
GW Pharma (GWPH) Gets a Hold Rating from Raymond James
In a report released yesterday, Danielle Brill from Raymond James maintained a Hold rating on GW...
Aphria Inc. stock underperforms Thursday when compared to competitors
Shares of Aphria Inc. shed 3.56% to $15.45 Thursday, on what proved to be an all-around positive...
Aphria Inc. stock underperforms Tuesday when compared to competitors
Shares of Aphria Inc. shed 0.74% to $14.67 Tuesday, on what proved to be an all-around mixed trad...
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics,...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Pea...
Medical Marijuana Market to grow by $ 27.72 bn during 2021-2025, Aphria Inc. and Aurora Cannabis...
NEW YORK, April 26, 2021 /PRNewswire/ -- Technavio has monitored the medical marijuana market in ...